← Back to Search

Other

CBT + Low FODMAP Diet for IBS

N/A
Recruiting
Led By Robert J. Shulman, MD
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial is testing whether biomarkers can predict which children with IBS will respond better to CBT or the low FODMAP diet.

Who is the study for?
This trial is for children aged 7-12 with functional gastrointestinal disorders like IBS, who experience abdominal pain without an organic cause. They must understand English due to the nature of assessments and treatments involved. Kids with past bowel surgery, chronic diseases like Crohn's or diabetes, developmental disorders, or those already on FODMAP diets or CBT are excluded.Check my eligibility
What is being tested?
The study aims to determine if certain biomarkers can predict whether a child would benefit more from Cognitive Behavioral Therapy (CBT) or a Low FODMAP Diet for managing symptoms of pediatric chronic pain associated with gastrointestinal issues.See study design
What are the potential side effects?
While not medication-based interventions, side effects may include discomfort from dietary changes in the low FODMAP diet group and emotional distress during cognitive behavioral therapy sessions as children learn to manage their pain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Symptom Improvement
Other outcome measures
Improvement in quality of life

Trial Design

2Treatment groups
Experimental Treatment
Group I: Low FODMAP dietExperimental Treatment1 Intervention
Low FODMAP diet
Group II: Cognitive Behavioral TherapyExperimental Treatment1 Intervention
Cognitive Behavioral Therapy

Find a Location

Who is running the clinical trial?

University of WashingtonOTHER
1,740 Previous Clinical Trials
1,847,420 Total Patients Enrolled
Baylor College of MedicineLead Sponsor
1,001 Previous Clinical Trials
6,002,002 Total Patients Enrolled
Robert J. Shulman, MDPrincipal InvestigatorBaylor College of Medicine

Media Library

Cognitive Behavioral Therapy (Other) Clinical Trial Eligibility Overview. Trial Name: NCT03823742 — N/A
Functional Abdominal Pain Disorder Research Study Groups: Cognitive Behavioral Therapy, Low FODMAP diet
Functional Abdominal Pain Disorder Clinical Trial 2023: Cognitive Behavioral Therapy Highlights & Side Effects. Trial Name: NCT03823742 — N/A
Cognitive Behavioral Therapy (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03823742 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible to enroll in this experimentation right now?

"Affirmative. The records on clinicaltrials.gov verify that, as of November 17th 2021, this research is still recruiting participants. Initially posted in February 2019, the trial seeks to enrol 250 individuals at 2 different sites."

Answered by AI

Is enrollment restricted to individuals below the age of 35 for this experiment?

"According to the parameters of this clinical trial, children aged between 7 and 12 are eligible for enrolment."

Answered by AI

How many individuals are contributing to this research endeavor?

"Indeed, the data on clinicaltrials.gov verifies that this medical research is currently enrolling potential participants. Initially posted on February 22nd 2019 and last modified on November 17th 2021, 250 patients need to be recruited from 2 sites."

Answered by AI

Are there any particular criteria for potential participants of this research?

"This clinical trial will accept 250 participants who are suffering from Irritable Bowel Syndrome and aged between 7 to 12 years old."

Answered by AI
~41 spots leftby Apr 2025